Corpus Intelligence IC Memo — TEXAS REHABILITATION HOSPITAL OF KEL 2026-04-27 01:25 UTC
IC Memo — TEXAS REHABILITATION HOSPITAL OF KEL
Investment Committee Memorandum | TX | 36 beds | Grade D | EBITDA uplift $1.0M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 673077

TEXAS REHABILITATION HOSPITAL OF KEL

LOCATIONTARRANT, TX·BEDS36·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

TEXAS REHABILITATION HOSPITAL OF KEL is a 36-bed community hospital in TARRANT, TX with $13.7M in net patient revenue and a 15.1% operating margin. The hospital serves a payer mix of 72.7% Medicare, 0.0% Medicaid, and 27.3% commercial.

Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.1% to 22.4% (+737bps).

Net Revenue HCRIS$13.7M
Current EBITDA COMPUTED$2.1M
Operating Margin COMPUTED15.1%
Occupancy HCRIS58.4%
Revenue / Bed COMPUTED$380K
Net-to-Gross HCRIS60.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
282
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 15.1% places it above the state median. Among 282 size-comparable peers (18-72 beds), the median margin is -3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 282 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TEXAS REHABILITATION HOSPITAL (Target)TX36$13.7M15.1%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
BAYLOR MEDICAL CENTER AT FRISCTX68$161.1M10.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$287K+210bp18mo
Cost to Collect4.5%2.5%$274K+200bp12mo
Denial Rate Reduction12.0%6.5%$272K+199bp12mo
A/R Days Reduction5200.0%3800.0%$166K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$287K
Cost to Collect
$274K
Denial Rate Reduction
$272K
A/R Days Reduction
$166K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.0M
Current EBITDA$2.1M
+ RCM Uplift+$1.0M
Pro Forma EBITDA$3.1M
Current Margin15.1%
Pro Forma Margin22.4%
WC Released (1x)$525K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.2M$23.7M7.47x49.5%
Base (11x exit)10.0x11.0x$3.2M$27.1M8.54x53.6%
Bull Case9.0x11.0x$2.9M$31.4M11.01x61.6%
Bull (12x exit)9.0x12.0x$2.9M$35.1M12.31x65.2%
Bear Case11.0x10.0x$3.5M$17.6M5.05x38.2%
Bear (11x exit)11.0x11.0x$3.5M$20.5M5.88x42.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 72.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 282 hospitals with 18-72 beds
  • Same-state prioritization (n=283)
  • Comp margins: P25=-26.9% / P50=-3.9% / P75=10.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.